(Q34989319)

5 August 2017

1 reference

title

Clinical Significance of FGF-23 in Patients with CKD. (English)

1 reference

5 August 2017

Domenico Russo

1

1 reference

PubMed ID

21603159

5 August 2017

Yuri Battaglia

series ordinal

2

1 reference

5 August 2017

26 April 2011

1 reference

International Journal of Nephrology

5 August 2017

1 reference

5 August 2017

2011

1 reference

5 August 2017

364890

1 reference

Creative Commons Attribution 3.0 Unported

5 August 2017

start time

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097014

Initial FGF23-mediated signaling occurs in the distal convoluted tubule

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097014

In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097014

FGFR3 and FGFR4 do not mediate renal effects of FGF23.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097014

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097014

FGF-23-Klotho signaling stimulates proliferation and prevents vitamin D-induced apoptosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097014

A bimodal association of vitamin D levels and vascular disease in children on dialysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097014

Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097014

Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097014

Regulation of fibroblast growth factor-23 signaling by klotho

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097014

Structural and biochemical properties of fibroblast growth factor 23.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097014

1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097014

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097014

FGF-21 as a novel metabolic regulator

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097014

Physiological regulation of renal sodium-dependent phosphate cotransporters

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097014

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097014

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097014

FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097014

Transcriptional activation of the cholesterol 7alpha-hydroxylase gene (CYP7A) by nuclear hormone receptors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097014

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097014

Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

8 July 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F364890

Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F364890

Inhibition of intestinal sodium-dependent inorganic phosphate transport by fibroblast growth factor 23.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F364890

Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F364890

Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F364890

Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F364890

Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F364890

Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F364890

Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F364890

FGF-23 in patients with end-stage renal disease on hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F364890

Severely reduced production of klotho in human chronic renal failure kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F364890

Relationship between circulating FGF23 and total body atherosclerosis in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F364890

High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F364890

Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F364890

FGF-23 and sFRP-4 in chronic kidney disease and post-renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F364890

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F364890

Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F364890

Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F364890

The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F364890

Does FGF23 toxicity influence the outcome of chronic kidney disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F364890

Regulation of fibroblast growth factor 23 production in bone in uremic rats.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097014

Clinical epidemiology of cardiovascular disease in chronic renal disease

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3097014

Vitamin D levels and patient outcome in chronic kidney disease

26 October 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F364890

Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism

21 January 2018

1 reference

12 December 2020

Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women

1 reference

12 December 2020

Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease (MMKD) Study

1 reference

12 December 2020

Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients

1 reference

12 December 2020

Determination of the elimination half-life of fibroblast growth factor-23

1 reference

12 December 2020

Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community

1 reference

12 December 2020

Vitamin D levels and early mortality among incident hemodialysis patients

1 reference

12 December 2020

Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes

1 reference

12 December 2020

Aortic pulse wave velocity index and mortality in end-stage renal disease

1 reference

12 December 2020

Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality.

1 reference

12 December 2020

Disordered mineral metabolism in hemodialysis patients: an analysis of cumulative effects in the Hemodialysis (HEMO) Study

1 reference

12 December 2020

Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study

1 reference

12 December 2020

Identifiers

DOI

10.4061/2011/364890

1 reference

5 August 2017

1 reference

5 August 2017

1 reference

PubMed ID

21603159